JAK2 and acute myeloid leukemia: In an analysis of primary AML cells, 76% had elevated Lyn kinase activity, while none had constitutive JAK2 activation; moreover, inhibition of Lyn activity (using genetic and small molecule inhibitors) in AML cell lines substantially decreased cell growth [75].